Matches in Wikidata for { <http://www.wikidata.org/entity/Q65376816> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q65376816 description "clinical trial" @default.
- Q65376816 description "ensayu clínicu" @default.
- Q65376816 description "klinisch onderzoek" @default.
- Q65376816 description "клінічне випробування" @default.
- Q65376816 description "կլինիկական փորձարկում" @default.
- Q65376816 name "Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl" @default.
- Q65376816 name "Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder" @default.
- Q65376816 type Item @default.
- Q65376816 label "Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl" @default.
- Q65376816 label "Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder" @default.
- Q65376816 prefLabel "Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl" @default.
- Q65376816 prefLabel "Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder" @default.
- Q65376816 P1132 Q65376816-C1C52D11-5518-40B1-BAAB-7F394759C9F4 @default.
- Q65376816 P1476 Q65376816-60B4E3FD-1AC4-459F-BE4A-CB8BE0E29CDC @default.
- Q65376816 P17 Q65376816-D09D2265-C675-4E6B-BAE8-575AFDE18EC2 @default.
- Q65376816 P2899 Q65376816-6FEE95B6-5DC6-44B7-BD7D-0CBB7F42DC20 @default.
- Q65376816 P3098 Q65376816-486D91BD-80F7-4169-9E76-6D1A6767102D @default.
- Q65376816 P31 Q65376816-3D1E6C8C-97AE-49B7-B8B0-1ED496F85B5E @default.
- Q65376816 P4135 Q65376816-73732730-C97B-4E18-B800-33CFFD05880E @default.
- Q65376816 P580 Q65376816-82595F6E-66ED-48E3-A8EE-29823428DDE2 @default.
- Q65376816 P582 Q65376816-603AC6F6-93FA-41F4-B1EB-4CFC169DE44F @default.
- Q65376816 P6099 Q65376816-92C1BFA8-67CB-4457-994F-EA447421B14D @default.
- Q65376816 P6153 Q65376816-0937712D-48BE-4901-8020-95CCF6E3FD29 @default.
- Q65376816 P6153 Q65376816-34C6463C-04D8-468D-9D5D-BBA45399CD7D @default.
- Q65376816 P6153 Q65376816-5EEEAB53-F894-467A-BD15-0283105BC291 @default.
- Q65376816 P6153 Q65376816-FBDCE20E-61EB-4B66-8618-695D7C9A6CCD @default.
- Q65376816 P8363 Q65376816-BA3B8F76-9ADF-46E0-A856-F595F54EB4A6 @default.
- Q65376816 P1132 "+314" @default.
- Q65376816 P1476 "A Phase 3, Double-blind, Randomized, Multi-center, Placebo Controlled, Dose-optimization Study Evaluating the Safety, Efficacy, and Tolerability of Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Adolescents Aged 13-17 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)" @default.
- Q65376816 P17 Q30 @default.
- Q65376816 P2899 "+13" @default.
- Q65376816 P3098 "NCT01081132" @default.
- Q65376816 P31 Q30612 @default.
- Q65376816 P4135 "+17" @default.
- Q65376816 P580 "2011-09-01T00:00:00Z" @default.
- Q65376816 P582 "2013-05-01T00:00:00Z" @default.
- Q65376816 P6099 Q42824827 @default.
- Q65376816 P6153 Q30269704 @default.
- Q65376816 P6153 Q30282378 @default.
- Q65376816 P6153 Q309331 @default.
- Q65376816 P6153 Q50037015 @default.
- Q65376816 P8363 Q78089383 @default.